An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies

Clinical trial NCT02712905 · TERMINATED

Trial details

NCT number: NCT02712905
Sponsor: Incyte Corporation
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumors and Hematologic Malignancy

Start date: 2016-05-05
Primary completion: 2022-04-14
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.